Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
AUROBINDO PHARMA Plunges by 5%; BSE HEALTHCARE Index Down 1.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Plunges by 5%; BSE HEALTHCARE Index Down 1.0%
Fri, 17 May 09:32 AM

AUROBINDO PHARMA share price has plunged 5% and is presently trading at Rs 725.

Meanwhile, the BSE HEALTHCARE Index is at 13,328 (down 1.0%).

Among the top losers in the BSE HEALTHCARE Index today is AUROBINDO PHARMA (down 5.1%).

NARAYANA HRUDAYALAYA LTD (up 1.8%) and SHILPA MEDICARE (up 1.3%) are among the top gainers today.

Over the last one year, AUROBINDO PHARMA has moved up from Rs 603 to Rs 725, registering a gain of Rs 122 (up 20.3%)..

The BSE HEALTHCARE has moved up from 13,285 to 13,328, registering a gain of 43 points (up 0.3%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DIVIS LABORATORIES (up 39.6%), DR. REDDYS LAB (up 38.1%) and SUVEN LIFESCIENCES (up 32.7%).

What About the Benchmark Indices?

The BSE Sensex is at 37,608 (up 0.5%). The top gainers among the BSE Sensex stocks today are YES BANK (up 5.3%). The most traded stocks in the BSE Sensex are YES BANK and SBI.

In the meantime, NSE Nifty is at 11,315 (up 0.3%). YES BANK (up 4.9%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,388 to 37,608, registering a gain of 2,220 points (up 6.2%).

AUROBINDO PHARMA Financial Update...

AUROBINDO PHARMA net profit stood at Rs 7 billion for the quarter ended December 2018, compared to a profit of Rs 6 billion a year ago. Net Sales rose 21.5% to Rs 52.7 billion during the period as against Rs 43.4 billion in October-December 2017.

For the year ended March 2018, AUROBINDO PHARMA reported 5.4% increase in net profit to Rs 24.2 billion compared to net profit of Rs 23.0 billion during FY17.

Revenue of the company grew 9.3% to Rs 165 billion during FY18.

The current Price to earnings ratio of AUROBINDO PHARMA, based on rolling 12 month earnings, stands at 17.5x.

Equitymaster requests your view! Post a comment on "AUROBINDO PHARMA Plunges by 5%; BSE HEALTHCARE Index Down 1.0%". Click here!


Stock Market Updates

Rising Oil Prices, Latest on the Jet Airways Saga, and Top Stocks in Action Today (Today's Market)

May 22, 2019 Pre-Open

On Tuesday, share markets in India fell sharply in the afternoon session and ended deep in the red after a volatile day of trading.

View More Indian Share Market News

Most Popular

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


May 21, 2019 (Close)